Iceland vs Sri Lanka: Tuberculosis treatment success rate
Iceland
79.0%
in 2023
Sri Lanka
80.0%
in 2023
Iceland rank
124th
Sri Lanka rank
123rd
Tuberculosis treatment success rate over time
- Iceland
- Sri Lanka
How they compare
Sri Lanka currently reports 80.0% against 79.0% in Iceland, a difference of 1.0%.
The two have swapped places 9 times across 24 shared years of data; in 2000 it was Iceland ahead.
Iceland ranks 124th and Sri Lanka ranks 123rd of 203 countries.
Across the 3 decades both report, Iceland averaged higher in 2 and Sri Lanka in 1.
Head to head by decade
| Decade | Iceland | Sri Lanka | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.6% | 84.1% | 6.5% | Iceland |
| 2010s | 92.5% | 85.6% | 6.9% | Iceland |
| 2020s | 58.0% | 80.5% | 22.5% | Sri Lanka |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, Iceland or Sri Lanka?
- Sri Lanka, at 80.0% against 79.0% in Iceland as of 2023.
- What is the difference in tuberculosis treatment success rate between Iceland and Sri Lanka?
- 1.0%, with Sri Lanka ahead.
- How many years of comparable data are there for Iceland and Sri Lanka?
- 24 years are reported by both, from 2000 to 2023.
- How do Iceland and Sri Lanka rank globally for tuberculosis treatment success rate?
- Iceland ranks 124th and Sri Lanka ranks 123rd of 203 countries.
- Where does this data come from?
- Global Tuberculosis Report, World Health Organization (WHO), published as Tuberculosis treatment success rate (% of new cases). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Tuberculosis treatment success rate is the percentage of all new tuberculosis cases (or new and relapse cases for some countries) registered under a national tuberculosis control programme in a given year that successfully completed treatment, with or without bacteriological evidence of success ("cured" and "treatment completed" respectively).